(3-tert-Butoxycarbonylamino-pyrrolidin-1-yl)-acetic acid, 250mg

5-BROMO-8-(TRIFLUOROMETHYL)QUINOLINE, 95.0%, 100mg

1-((3-(5-Nitrofuran-2-yl)allylidene)amino)imidazolidine-2,4-dione, 95.0%, 5g

4'-(Pyridin-4-yl)-[1,1'-biphenyl]-3,5-dicarboxylic acid, 98%, 1g

Methyl 3-oxo-1,2,3,4-tetrahydroisoquinoline-7-carboxylate, 95%, 100mg

Methyl 3,6-dibromo-2-fluorobenzoate, 98%, 1g

2-Butyl-5-nitrobenzofuran, 95.0%, 100g

2-Benzyloxy-6-fluorobenzoic acid, 95+%, 1g

4-CYANO-3-METHYLBENZALDEHYDE, 95.0%, 25g

1H-INDAZOLE, 7-BROMO-1-METHYL-5-NITRO-, 95%, 250mg

(S)-2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-3-(2-methoxyphenyl)propanoic acid, 98%, 1g

Citidina, mínimo 99 %, para bioquímica, 25 g, envase de plástico.

2-((TERT-BUTOXYCARBONYL)AMINO)-3-(2-CYANOPHENYL)PROPANOIC ACID, 95.0%, 250mg